Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma
NCT ID: NCT07201415
Last Updated: 2025-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-01-01
2027-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy
NCT04703712
A Study on the Treatment Strategy of NVG Secondary to PDR
NCT05156021
UCP Glaucoma Treatment for Primary Glaucoma in China
NCT04145830
Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma
NCT02964676
Zonulo-hyaloido-vitrectomy for Malignant Glaucoma
NCT02613143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical Treatment Group
The patient will undergo a minimally invasive suprachoroidal drainage procedure
minimally invasive suprachoroidal drainage
minimally invasive suprachoroidal drainage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
minimally invasive suprachoroidal drainage
minimally invasive suprachoroidal drainage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Eye infection within two weeks before surgery
* Non-glaucomatous intraocular diseases that affect intraocular pressure (choroidal hemorrhage or detachment, retinal detachment, lens subluxation, thyroid eye disease, clinically significant macular edema, eye tumors, etc.)
* Visual acuity of non-study eyes \< 0.05
* Congenital or acquired factors lead to ciliary body anatomical abnormalities
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongnan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20250904
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.